Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | XBP1 | P17861 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11652356 | 0.89 | CYP1A2 (0.80) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL23204027 | 0.86 | CYP1A2 (0.76) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL4205954 | 0.86 | CYP1A2 (0.76) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL11644037 | 0.86 | CYP1A2 (0.76) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL69310 | 0.84 | HPGD (1.00) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL18722030 | 0.84 | CYP1A2 (0.72) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL11279116 | 0.84 | CYP1A2 (0.72) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL7046856 | 0.83 | CYP1A2 (0.71) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL18125047 | 0.82 | CYP1A2 (0.70) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 | |
| SCHEMBL16504003 | 0.82 | CYP1A2 (0.70) | CYP1A2CYP2C9CYP2C19HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107376989-B | Cu-AEI molecular sieve catalyst synthesis and application | 中触媒新材料股份有限公司 | 2021-01-05 | — | — | CN | claimed |
| CN-107376989-B | Cu-AEI molecular sieve catalyst synthesis and application | 中触媒新材料股份有限公司 | 2021-01-05 | — | — | CN | disclosed |
| US-8852757-B2 | Organic electroluminescence element, lighting device and display device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| EP-2382225-B1 | ORGANIC METAL COMPLEXES FOR USE IN OPTOELECTRONIC DEVICES | GEN ELECTRIC (US) | 2013-08-28 | — | — | EP | disclosed |
| US-8304419-B2 | Chemical compounds | GLAXOSMITHKLINE LLC (US) | 2012-11-06 | — | — | US | disclosed |
| EP-2382225-A1 | ORGANIC METAL COMPLEXES FOR USE IN OPTOELECTRONIC DEVICES | General Electric Company (US) | 2011-11-02 | — | — | EP | disclosed |
| US-20100216746-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2010-08-26 | — | — | US | disclosed |
| WO-2010074957-A1 | ORGANIC METAL COMPLEXES FOR USE IN OPTOELECTRONIC DEVICES | GENERAL ELECTRIC COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| US-20100156278-A1 | ORGANIC METAL COMPLEXES FOR USE IN OPTOELECTRONIC DEVICES | GENERAL ELECTRIC COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
| US-20100045171-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-4070366-A | RING ALKYLATION OF SUBSTITUTED PYRROLES, ONE STEP | CANADIAN PATENTS & DEVELOPMENT LIMITED (US) | 1978-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100156278-A1 | ORGANIC METAL COMPLEXES FOR USE IN OPTOELECTRONIC DEVICES | SCO2, C1S, C1R | CYP1A2 987/4885CYP2C9 938/4885CYP2C19 883/4885 |
| US-20100216746-A1 | CHEMICAL COMPOUNDS | SAMHD1, POLRMT, NUDT1 | CYP1A2 301/4885CYP2C9 720/4885CYP2C19 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.